期刊文献+

乳腺癌基因药物网络模型的构建与分析 被引量:2

Construction and analysis of a breast cancer gene-drug network model
下载PDF
导出
摘要 目的构建乳腺癌基因药物网络模型,提取并预测乳腺癌相关基因药物间的关联。方法基于"ABC理论"和关联规则,提出一种生物实体间关联算法,以乳腺癌为例,提取乳腺癌相关基因与基因、药物与药物、基因与药物3种不同层次的关联,采用R语言实现网络模型的可视化,最后利用ROC曲线验证算法可靠性。结果得到乳腺癌相关基因185种,98种不同关联;乳腺癌相关药物97种,170种不同关联;乳腺癌相关基因与药物网络中含有127种基因和77种药物,共384种不同关联。结论乳腺癌的基因药物之间存在大量不同强度的关联,并且发现一些具有高度关联但尚未验证的生物实体对,为乳腺癌个性化诊治提供了新的研究思路。 Objective To construct a breast cancer gene- drug network model for extracting and predicting the correlations between breast cancer- related genes and drugs. Methods We developed an algorithm based on the ABC principle and the association rules to obtain the correlations between the biological entities. For breast cancer, we constructed 3 different correlations(gene-gene, drug-drug and gene-drug) and used the R language to implement the associated network model. The reliability of the algorithm was verified by ROC curve. Results We identified 185 breast cancer- associated genes and 98 associations between them, 97 drugs and 170 associations between them. The breast cancer genes-drugs network contained 127 genes and 77 drugs with 384 associations between them. Conclusion We identified a large number of different correlations between the breast cancer- related genes and drugs and close correlations between some biological entity pairs that have not yet been reported, which may provide a new strategy for experimental design for testing personalized breast cancer treatment.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2016年第2期170-179,共10页 Journal of Southern Medical University
基金 国家自然科学基金(31500999) 安徽省高等学校自然科学研究一般项目(KJ2015B057by)~~
关键词 乳腺癌 基因 药物 网络模型 R语言 breast cancer gene drug network model R language
  • 相关文献

参考文献2

二级参考文献95

  • 1胡沙,王静,李智敏,郭剑锋,于利利,杨纯,王泽华.EZH2基因在人卵巢癌顺铂耐药株中的表达及其对细胞耐药性的影响[J].肿瘤,2010,30(9):748-752. 被引量:9
  • 2彭燕,陈海滨,苏中静,陈玲,张锦,许丽艳.EZH2蛋白在食管癌组织中的表达[J].解剖学报,2006,37(6):650-655. 被引量:6
  • 3Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of thepRB-E2F pathway, essential for proliferation and amplified incancer[j]. EMBO J, 2003,22(20): 5323-35.
  • 4Strahl BD, Allis CD. The language of covalent histone modific-ations[j]. Nature, 2000,403(6765): 41-5.
  • 5Suzuki MM, Bird A. DNA methylation landscapes: provocativeinsights from epigenomics[J]. Nat Rev Genet, 2008, 9(6): 465-76.
  • 6J SJ, Lange CA. Roles of the EZH2 histone methyhransferase incancer epigenetics[J]. Mutat Res, 2008, 647(1/2): 21-9.
  • 7Guglielmelli P, Biamonte F, Score J, et al. EZH2 mutational statuspredicts poor survival in myelofibrosis [J]. Blood, 2011, 118(19):5227-34.
  • 8Esophageal cancer incidence, mortality and prevalence worldwidein 2008. summary international agency for research on cancer.GLOBOCAN 2008. http://globocan.iarc.fr/factsheet.asp#BOTH.Accessed on 2012.Sep.20.
  • 9Guenther MG, Levine SS, Boyer LA, et al. A chromatin landmarkand transcription initiation at most promoters in human cells [j].Cell, 2007, 130(1): 77-88.
  • 10Kuzmichev A,Jenuwein T, Tempst P, et al. Different Ezh2-containing complexes target methylation of histone HI ornucleosomal histone H3[j]. Mol Cell, 2004,14(2): 183-93.

共引文献18

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部